Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer

A prospective study was performed in patients with non-small cell lung cancer (NSCLC) to evaluate the prognostic importance of multiple molecular marker (p53, c-Ki-ras, c-erbB-2) testing. 103 patients with potentially curative resections (RO resection) for NSCLC in histopathological stages I–IIIA we...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, P M, Praeuer, H W, Stoeltzing, O, Boehm, J, Manning, J, Metzger, R, Fink, U, Wegerer, S, Hoelscher, A H, Roth, J A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374666/
https://www.ncbi.nlm.nih.gov/pubmed/10945494
http://dx.doi.org/10.1054/bjoc.2000.1287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374666/
https://www.ncbi.nlm.nih.gov/pubmed/10945494
http://dx.doi.org/10.1054/bjoc.2000.1287

Ejemplares similares